18-19 COVID-19 vaccine candidates in pipeline: Union Health Minister Press Trust of India Feb 15, 2021 In the next two to three weeks, vaccinations against COVID-19 will be started for people above 50 years of age
More COVID-19 vaccines will be introduced in India: Health Minister Press Trust of India Jan 28, 2021 The health minister said the pandemic has also resulted in heightened nationalism, but it has also shown us how important global…
Dr Harsh Vardhan inaugurates CEPI centralised network lab at DBT-THSTI Faridabad virtually Press Information Bureau Jan 5, 2021 The CEPI laboratory will be a great addition to the ability of THSTI to enhance the quality of services towards making vaccine and…
Dr Harsh Vardhan nominated to the Board of GAVI, The Vaccine Alliance Press Information Bureau Dec 29, 2020 Dr Vardhan will be representing the SEARO/WPRO constituency on the GAVI Board
Serum Institute of India launches indigenously developed pneumococcal vaccine,… EP News Bureau Dec 28, 2020 This WHO pre-qualified PCV is specially tailored to the prevailing serotype prevalence of S. pneumoniae in India and other regions…
Homegrown COVID-19 vaccine final trials may conclude within two months: India Reuters Nov 23, 2020 ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers
Dr Harsh Vardhan gives away Gandhian Young Technological Awards in two categories Press Information Bureau Nov 5, 2020 Fourteen awards and eleven appreciations under SITARE-GYTI, seven awards and 16 appreciations under SRISTI-GYTI were presented
Dr Harsh Vardhan launches DST initiative SERB – POWER for women scientists Press Information Bureau Oct 29, 2020 Promoting Opportunities for Women in Exploratory Research (POWER) is a scheme to mitigate gender disparity in science and…
Dr Harsh Vardhan launches CuRED, CSIR website on COVID-19 clinical trials Press Information Bureau Oct 21, 2020 It provides information about the drugs, diagnostics and devices including the current stage of the trials, partnering…
Serum India, Bharat Biotech to test intranasal COVID-19 vaccines post regulatory nod: Dr Harsh… EP News Bureau Oct 19, 2020 He clarified that Phase III clinical trial is generally with thousands of participants, sometimes even close to 30,000 to 40,000…